Search - tctmd.com

Displaying 261 - 280 of 372

Sort: Relevancy | Date

Presentation TCT 2014

Complication Case #2: Stent Thrombosis and Abrupt Closure

Presenter: Run-Lin Gao, Martin B. Leon, Gregg W. Stone, Qi Zhang

September 13, 2014

Presentation TCT 2014

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Kevin J. Croce

September 13, 2014

Presentation TCT 2014

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Presenter: Patrick W. Serruys, George D. Dangas

September 13, 2014

Presentation TCT 2014

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Presenter: Valentin Fuster, Pieter C. Smits

September 13, 2014

News Conference News TCT 2014

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

September 13, 2014

News Conference News TCT 2014

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

Todd Neale

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Conference News TCT 2013

Studies Find Differing Benefits of Platelet, Genotype Testing

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

Presentation TCT 2013

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

Presenter: Yasuhiro Honda

October 30, 2013

News Conference News TCT 2013

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

October 30, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

Advertisement

Complication Case #2: Stent Thrombosis and Abrupt Closure

Restenosis and Stent Thrombosis

HORIZONS-AMI and EUROMAX Stent Thrombosis: Predictors of Stent Thrombosis and Risk for 30-Day Mortality After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

TCT 644: Stent Thrombosis Rates of the Biodegradable Polymer, Biolimus-Eluting Stent Versus the Durable Polymer, Everolimus-Eluting Stent in All Comers Undergoing PCI: A Pooled Analysis of the COMPARE II and NEXT Trials at 1 Year

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

COMPARE II: BES, EES Show Similar Outcomes at Three Years

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Studies Find Differing Benefits of Platelet, Genotype Testing

OPTIMIZE: 3-Month DAPT Safe with ZES

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Assessment of Late Stent Complications with Intravascular Imaging: Restenosis, Late Stent Malapposition, and Very Late Stent Thrombosis

SORT-OUT VI: Permanent Polymer ZES Noninferior to Biodegradable BES in All-Comers Study

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

PCI vs. CABG a Close Call in Some Complex Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content